Used in biomedical research to quantify EMMPRIN (CD147), a glycoprotein involved in tumor progression, inflammation, and tissue remodeling. The ELISA kit enables detection of EMMPRIN levels in human serum, plasma, cell lysates, and other biological fluids. It is widely applied in cancer studies, particularly in monitoring tumor cell invasion and metastasis, as EMMPRIN induces matrix metalloproteinases (MMPs) that degrade extracellular matrix. Also used in research on autoimmune diseases, cardiovascular conditions, and viral infections such as HIV and SARS-CoV-2, where CD147 acts as a co-receptor for cellular entry. The assay supports drug development and evaluation of therapeutic responses by providing a reliable measure of EMMPRIN expression changes under experimental conditions.